Page last updated: 2024-08-26

olivacine and Leukemia P388

olivacine has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atassi, G; Bisagni, E; Burbridge, M; Guilbaud, N; Jan, M; Kraus-Berthier, L; Pierré, A; Rouillon, MH; Saint-Dizier, D; Visalli, M	1
Besselièvre, R; Chevallier-Multon, MC; Husson, HP; Jacquemin-Sablon, A; Le Pecq, JB	1

Other Studies

2 other study(ies) available for olivacine and Leukemia P388

Article	Year
In vivo antitumor activity of S 16020-2, a new olivacine derivative. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6 Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Breast Neoplasms; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Ellipticines; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured	1996
Comparative cytotoxicities of a series of ellipticine and olivacine derivatives on multidrug resistant cells of human and murine origins. Anti-cancer drug design, 1990, Volume: 5, Issue:4 Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Ellipticines; Gene Amplification; Humans; Leukemia P388; Lipid Metabolism; Membrane Glycoproteins; Mice; Phenotype; Solubility; Structure-Activity Relationship; Tumor Cells, Cultured	1990

Article

Year

In vivo antitumor activity of S 16020-2, a new olivacine derivative.

Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Breast Neoplasms; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Ellipticines; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured

1996

Comparative cytotoxicities of a series of ellipticine and olivacine derivatives on multidrug resistant cells of human and murine origins.

Anti-cancer drug design, 1990, Volume: 5, Issue:4

Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Ellipticines; Gene Amplification; Humans; Leukemia P388; Lipid Metabolism; Membrane Glycoproteins; Mice; Phenotype; Solubility; Structure-Activity Relationship; Tumor Cells, Cultured

1990